Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Allogeneic Hematopoietic Stem Cell Transplantation Recipient”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Active Not RecruitingNCT04177004
What this trial is testing

Human Lysozyme Goat Milk for the Prevention of Graft Versus Host Disease in Patients With Blood Cancer Undergoing a Donor Stem Cell Transplant

Who this might be right for
Allogeneic Hematopoietic Stem Cell Transplant RecipientHematopoietic and Lymphoid Cell Neoplasm
City of Hope Medical Center 52
Early research (Phase 1)Active Not RecruitingNCT03560752
What this trial is testing

CMV-MVA Triplex Vaccination of Stem Cell Donors in Preventing CMV Viremia in Participants With Allogeneic Transplant

Who this might be right for
Accelerated Phase CML, BCR-ABL1 PositiveAcute Lymphoblastic Leukemia in RemissionAcute Myeloid Leukemia in Remission+11 more
City of Hope Medical Center 34
Early research (Phase 1)Study completedNCT03600155
What this trial is testing

Nivolumab and Ipilimumab After Donor Stem Cell Transplant in Treating Patients With High Risk Refractory or Relapsed Acute Myeloid Leukemia or Myelodysplastic Syndrome

Who this might be right for
Allogeneic Hematopoietic Stem Cell Transplantation RecipientMyelodysplastic SyndromeRecurrent Acute Myeloid Leukemia+1 more
M.D. Anderson Cancer Center 29
Not applicableUnknownNCT05675826
What this trial is testing

The Impact of Donor COVID-19 Infection Status on the Recipient in Allo-HSCT

Who this might be right for
COVID-19Hematopoietic Stem Cell Transplantation
Chen Suning 40
Early research (Phase 1)WithdrawnNCT03531281
What this trial is testing

Human Lysozyme Goat Milk in Treating Patients With Blood Cancer Undergoing Donor Stem Cell Transplant

Who this might be right for
Hematopoietic and Lymphoid Cell NeoplasmHematopoietic Cell Transplantation Recipient
City of Hope Medical Center
Very early researchEnded earlyNCT03272633
What this trial is testing

Irradiated Donor Cells Following Stem Cell Transplant in Controlling Cancer in Patients With Hematologic Malignancies

Who this might be right for
Acute Lymphoblastic LeukemiaAcute Myeloid Leukemia in RemissionHematopoietic Cell Transplantation Recipient+16 more
Rutgers, The State University of New Jersey 2
Testing effectiveness (Phase 2)Study completedNCT01701986
What this trial is testing

Gemcitabine Hydrochloride, Clofarabine, and Busulfan Before Donor Stem Cell Transplant in Treating Patients With Refractory B-Cell or T-Cell Non-Hodgkin Lymphoma or Hodgkin Lymphoma

Who this might be right for
Hematopoietic Cell Transplantation RecipientRefractory B-Cell Non-Hodgkin LymphomaRefractory Hodgkin Lymphoma+1 more
M.D. Anderson Cancer Center 64
Testing effectiveness (Phase 2)Looking for participantsNCT05554068
What this trial is testing

Immunogenicity of Zoster Vaccine in Allogeneic Hematopoietic Stem Cell Transplant Recipients

Who this might be right for
Shingles
Loyola University 100
Not applicableUnknownNCT03806764
What this trial is testing

Cytomegalovirus (CMV) Reactivation in Allogeneic HSCT Recipient

Who this might be right for
Cytomegalovirus InfectionsHaematological MalignancyOrgan or Tissue Transplant; Complications+1 more
Melbourne Health 370
Early research (Phase 1)Study completedNCT01911039
What this trial is testing

Phase 1 Infused Donor T Regulatory Cells in Steroid Dependent/Refractory Chronic GVHD

Who this might be right for
Graft Versus Host DiseaseAllogeneic Hematopoietic Cell Transplant Recipient
Laura Johnston 14
Early research (Phase 1)Study completedNCT01822509
What this trial is testing

Ipilimumab or Nivolumab in Treating Patients With Relapsed Hematologic Malignancies After Donor Stem Cell Transplant

Who this might be right for
Allogeneic Hematopoietic Stem Cell Transplant RecipientMyeloproliferative NeoplasmRecurrent Acute Lymphoblastic Leukemia+8 more
National Cancer Institute (NCI) 71
Large-scale testing (Phase 3)UnknownNCT04674345
What this trial is testing

Sorafenib Maintenance for Prophylaxis of Leukemia Relapse in Allo-HSCT Recipients With FLT3 Negative Acute Leukemia

Who this might be right for
Acute LeukemiaRelapseHematopoietic Stem Cell Transplantation
Nanfang Hospital, Southern Medical University 346
Testing effectiveness (Phase 2)Study completedNCT03925532
What this trial is testing

Denosumab in Treating Patients With Bone Loss Due to Donor Stem Cell Transplant

Who this might be right for
Allogeneic Hematopoietic Stem Cell Transplantation RecipientOsteopeniaOsteoporosis
Roswell Park Cancer Institute 30
Early research (Phase 1)Active Not RecruitingNCT03726307
What this trial is testing

Allogeneic Regulatory Dendritic Cell (DCreg) Renal Study

Who this might be right for
Kidney TransplantRenal Transplant Recipients
Angus W. Thomson PhD DSc 28
Large-scale testing (Phase 3)Study completedNCT01699412
What this trial is testing

Clinical Trial With Clobetasol and Dexamethasone for Topical Treatment of Oral Lesions of Chronic Graft-versus-host Disease

Who this might be right for
Graft vs Host DiseaseOral Manifestations
Grupo de Estudos Multicentricos em Onco-Hematologia 28
Testing effectiveness (Phase 2)Ended earlyNCT00602446
What this trial is testing

Deferasirox in Treating Patients With Iron Overload After Undergoing a Donor Stem Cell Transplant

Who this might be right for
Breast CancerIron OverloadLeukemia+5 more
Masonic Cancer Center, University of Minnesota 4
Not applicableUnknownNCT00587574
What this trial is testing

Prospective Phase II Study for Assessment of Regulatory Immune Cell Populations After Allogeneic HSCT

Who this might be right for
Allogeneic Hematopoietic Cell Transplant Recipients
Medical University of Vienna 150
Not applicableNot Yet RecruitingNCT07644481
What this trial is testing

Efficacy and Safety of the CloB2M (Clofarabine Combined With Busulfan and Melphalan) Conditioning Regimen in Allogeneic Hematopoietic Stem Cell Transplantation for Adult Patients With Acute Myeloid Leukemia in First Complete Remission

Who this might be right for
AML (Acute Myelogenous Leukemia)Allogeneic Hematopoietic Stem Cell Transplantation Recipient
Institute of Hematology & Blood Diseases Hospital, China 30
Early research (Phase 1)Ended earlyNCT00909948
What this trial is testing

Intentional Rejection of the Donor Graft Using Recipient Leukocyte Infusion(s) Following Nonmyeloablative Allogeneic Stem Cell Transplant

Who this might be right for
Non Hodgkin's LymphomaHodgkin DiseaseMultiple Myeloma
Massachusetts General Hospital 7
Large-scale testing (Phase 3)Study completedNCT02137772
What this trial is testing

Letermovir (MK-8228) Versus Placebo in the Prevention of Clinically-Significant Cytomegalovirus (CMV) Infection in Adult, CMV-Seropositive Allogeneic Hematopoietic Stem Cell Transplant Recipients (MK-8228-001)

Who this might be right for
Prevention of CMV Infection or Disease
Merck Sharp & Dohme LLC 570
Next Page